2010 2013 Terpenes Treatment 
The Cannigma
MAY 13, 2022
Over 10% of US adults have suffered from some degree of daily pain for at least three months, so the need for improved treatment is clear. The best type of cannabis for dealing with chronic pain tends to be type I or type II strain with a terpene profile that includes linalool, pinene, beta-caryophyllene, limonene, or myrcene.
FloridaMarijuana.net
OCTOBER 6, 2018
More than ever, cannabis can aid in the treatment of chronic disease and as a supplement to a patient’s healthcare regime. As researchers dive into the depths of the cannabinoid system it is becoming clear that cannabis terpenes are just as vital to a plant’s efficacy as are cannabinoids. Paduch, Kandefer-Szersze?,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
JANUARY 3, 2023
You’ll want a specific combination of cannabinoids and terpenes, and what works for one person may not work for the next. The best strains for period pain are a Type I or Type II chemovar with a terpene profile that includes linalool, pinene, and beta-caryophyllene. Best terpenes for period pain. Beta-Caryophyllene.
Alchimia
JUNE 20, 2016
A study published in February 2015 in the Pharmacology & Pharmacy journal showed that a CBD-rich extract from cannabis plants is much more efficient than CBD used in its pure form , mainly due the presence of other cannabinoids, terpenes and other molecules that greatly increase the dosage/efficiency ratio of CBD.
Cannabis Law Report
NOVEMBER 24, 2021
It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). Research into the plant’s chemical compounds has also revealed a rich array of terpenes and flavonoids that may also account for the plant’s therapeutic effects (Kotsirilos and McGregor 2021 ).
Green Relief
MAY 13, 2018
Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. In 2013, the International Journal of Molecular Science reported on how TBI is affected by diurnal variations of the endocannabinoid system. An estimated 4 million to 6 million Americans are on disability because of TBI.
Green Relief
MAY 12, 2018
Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. In 2013, the International Journal of Molecular Science reported on how TBI is affected by diurnal variations of the endocannabinoid system. An estimated 4 million to 6 million Americans are on disability because of TBI.
Expert insights. Personalized for you.
111 
Let's personalize your content